Business UpdateJul 23, 2026, 04:12 PM
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Event
AI Summary
MindWalk Holdings Corp. publicly demonstrated ReefIQ™, its biological context layer for AI drug discovery, at AMD's Advancing AI 2026 event. ReefIQ™ aims to reconnect fragmented biological data, enabling AI models to reason over a governed, queryable context, and runs on AMD Instinct™ compute. This demonstration marks the first public showing of the platform, which was introduced in June 2026, and is designed to enhance the trustworthiness of AI reasoning in drug discovery.
Key Highlights
- MindWalk unveiled the first public demonstration of ReefIQ™ at AMD's Advancing AI 2026 event.
- ReefIQ™ is a biological context layer for AI drug discovery, running on AMD Instinct™.
- It reconnects fragmented discovery data into governed, queryable biological context for AI models.
- HYFT® Technology provides the biological representation foundation for ReefIQ™.
- LensAI™ is the reasoning and application layer that uses ReefIQ's context.
- The demonstration highlights ReefIQ's ability to make AI reasoning trustworthy in regulated settings.
- MindWalk's business development team will engage customers and partners at the event.
Price Impact
More from HYFT